Zacks.com on MSN7d
Amedisys (AMED) Earnings Expected to Grow: Should You Buy?The market expects Amedisys (AMED) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2024. This widely-known consensus outlook ...
Recent developments in the legal battle over the planned $3.3 billion UnitedHealth Group (NYSE: UHG) acquisition of Amedisys (Nasdaq: AMED) have moved the ...
UnitedHealth Group said in a court filing it is working with Amedisys to identify potential buyers for at least 128 home ...
UnitedHealth Group Inc. is withdrawing its motion to dismiss the Justice Department’s lawsuit seeking to block its $3.3 ...
UnitedHealth's (NYSE:UNH) planned $3.3 billion acquisition of Amedisys (NASDAQ:AMED) is likely to close despite reports that ...
UnitedHealth Group says the Justice Department’s antitrust challenge to its proposed $3.3 billion purchase of Amedisys is wrong ... hospice and home care business, the two companies argue ...
UnitedHealth Group's Inc.'s multibillion-dollar acquisition of Amedisys Inc. might not be ... the largest M&A deal of 2022 according to Business Journal research. That deal was also delayed ...
Two whistleblowers have adequately alleged that Amedisys Inc. violated the False Claims Act by improperly billing Medicare and other federal health-care programs for home health services, a New York ...
BATON ROUGE, La., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and nine-month periods ended September 30, 2024. Three-Month ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback